News

How To Break The Leadership Glass Ceiling In The Biotech Industry

November 5, 2022

Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health

September 7, 2022

A Transforming Life-Science Industry That’s Going To Change Our Lives

August 29, 2022

Dr. Leen Kawas: A Successful Biopharma Entrepreneur, Inventor, an Inspiration and Mother

August 25, 2022

Propel Bio Partners Launches With Backing of Richard Kayne

March 18, 2022

Former Athira CEO Leen Kawas Reemerges at Startup Propel Bio Partners

March 18, 2022

Propel Bio Partners Commences Operations

March 18, 2022

Portfolio Company News

Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

January 10, 2023

Persephone Biosciences Announces First Participant Enrolled in Proprietary My Baby Biome Study of Infant Gut Health

August 08, 2022

Propel co-lead Persephone’s $15M seed financing round. Persephone is a synthetic biology company reimagining patient and infant health through the development of microbiome-based medicine

July 19, 2022

Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

April 12, 2022

Persephone Biosciences Announces Collaboration with Janssen for Colorectal Arm of ARGONAUT Study

December 07, 2021